DDrare: Database of Drug Development for Rare Diseases

87. 肺静脈閉塞症／肺毛細血管腫症
［臨床試験数：3，薬物数：4（DrugBank：3），標的遺伝子数：4，標的パスウェイ数：43］

Searched query = "Pulmonary veno-occlusive disease", "Pulmonary capillary hemangiomatosis", "PVOD", "PCH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bevacizumab; Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec); Glutamine; Imatinib

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00891527 (ClinicalTrials.gov)	October 2008	30/4/2009	Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis	Adjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein Stenosis	Pulmonary Veno Occlusive Disease	Drug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)	Boston Children's Hospital	NULL	Completed	N/A	N/A	All	50	Phase 1;Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00891527
(ClinicalTrials.gov)

October 2008

30/4/2009

Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

Adjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein Stenosis

Pulmonary Veno Occlusive Disease

Drug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)

Boston Children's Hospital

NULL

Completed

N/A

All

Phase 1;Phase 2

United States